SARA FARMER: Open Payments
NPI 1538597992 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$300 in 17 payments from 9 companies in 2025. Trend: 2023 $784 · 2024 $577 · 2025 $300
Food & beverage: $300
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $65 |
| Novartis Pharmaceuticals Corporation | 4 | $65 |
| Grifols USA, LLC | 2 | $46 |
| Medtronic, Inc. | 1 | $33 |
| Lilly USA, LLC | 2 | $29 |
| Dexcom, Inc. | 1 | $18 |
| ABIOMED | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: LEQVIO, Prolastin-C Liquid, Ozempic, INTELLIS ADAPTIVESTIM, MOUNJARO, DEXCOM G7 GSS (161), Rybelsus, Cologuard Collection Kit.
Industry payments across KS — which companies pay providers there.
